PRLX-93936

PRLX-93936 is a selective small molecule inhibitor targeting the Ras pathway. It modulates RAS/JNK-associated protein phosphorylation, leading to caspase-dependent apoptosis and cell cycle arrest. This compound demonstrates anticancer activity and is utilized in vitro for mechanistic studies in oncology research, particularly involving Ras-driven cancer models.